Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 512081, 11 pages
http://dx.doi.org/10.1155/2014/512081
Review Article

Systematic Analysis of the Multiple Bioactivities of Green Tea through a Network Pharmacology Approach

1Shanghai Key Laboratory of New Drug Design, State Key Laboratory of Bioreactor Engineering, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China
2School of Pharmacy, Second Military Medical University, Shanghai 200433, China

Received 17 May 2014; Revised 5 November 2014; Accepted 13 November 2014; Published 30 November 2014

Academic Editor: Kuang C. Lai

Copyright © 2014 Shoude Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Mukhtar and N. Ahmad, “Tea polyphenols: prevention of cancer and optimizing health,” The American Journal of Clinical Nutrition, vol. 71, no. 6, supplement, pp. 1698S–1702S, 2000. View at Google Scholar
  2. D. L. McKay and J. B. Blumberg, “The role of tea in human health: an update,” Journal of the American College of Nutrition, vol. 21, no. 1, pp. 1–13, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. F. L. Chung, J. Schwartz, C. R. Herzog, and Y. M. Yang, “Tea and cancer prevention: studies in animals and humans,” Journal of Nutrition, vol. 133, no. 10, pp. 3268S–3274S, 2003. View at Google Scholar · View at Scopus
  4. M. Reto, M. E. Figueira, H. M. Filipe, and C. M. M. Almeida, “Chemical composition of green tea (Camellia sinensis) infusions commercialized in Portugal,” Plant Foods for Human Nutrition, vol. 62, no. 4, pp. 139–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. S. B. Wan, D. Chen, Q. P. Dou, and T. H. Chan, “Study of the green tea polyphenols catechin-3-gallate (CG) and epicatechin-3-gallate (ECG) as proteasome inhibitors,” Bioorganic and Medicinal Chemistry, vol. 12, no. 13, pp. 3521–3527, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. H. Miean and S. Mohamed, “Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants,” Journal of Agricultural and Food Chemistry, vol. 49, no. 6, pp. 3106–3112, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hämäläinen, R. Nieminen, P. Vuorela, M. Heinonen, and E. Moilanen, “Anti-inflammatory effects of flavonoids: Genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages,” Mediators of Inflammation, vol. 2007, Article ID 45673, 10 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Khan, F. Afaq, M. Saleem, N. Ahmad, and H. Mukhtar, “Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate,” Cancer Research, vol. 66, no. 5, pp. 2500–2505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Li and B. Zhang, “Traditional Chinese medicine network pharmacology: theory, methodology and application,” Chinese Journal of Natural Medicines, vol. 11, no. 2, pp. 110–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Azmi, “Network pharmacology for cancer drug discovery: are we there yet?” Future Medicinal Chemistry, vol. 4, no. 8, pp. 939–941, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. von Eichborn, M. S. Murgueitio, M. Dunkel, S. Koerner, P. E. Bourne, and R. Preissner, “PROMISCUOUS: a database for network-based drug-repositioning,” Nucleic Acids Research, vol. 39, no. 1, pp. D1060–D1066, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Gong, C. Cai, X. Liu et al., “ChemMapper: a versatile web server for exploring pharmacology and chemical structure association based on molecular 3D similarity method,” Bioinformatics, vol. 29, no. 14, pp. 1827–1829, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. G. A. Maggiora and M. A. Johnson, Concepts and Applications of Molecular Similarity, John Wiley & Sons, New York, NY, USA, 1990.
  14. X. Liu, H. Jiang, and H. Li, “SHAFTS: a hybrid approach for 3D molecular similarity calculation. 1. method and assessment of virtual screening,” Journal of Chemical Information and Modeling, vol. 51, no. 9, pp. 2372–2385, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Lu, X. Liu, X. Cao et al., “SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration,” Journal of Medicinal Chemistry, vol. 54, no. 10, pp. 3564–3574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Liu, S. Ouyang, B. Yu et al., “PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach,” Nucleic Acids Research, vol. 38, no. 2, pp. W609–W614, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Franceschini, D. Szklarczyk, S. Frankild et al., “STRING v9.1: protein-protein interaction networks, with increased coverage and integration,” Nucleic Acids Research, vol. 41, no. 1, pp. D808–D815, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Peng, W. Xu, J. Zheng et al., “The disease and gene annotations (DGA): an annotation resource for human disease,” Nucleic Acids Research, vol. 41, no. 1, pp. D553–D560, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Liu, D. Y. Zhang, W. Zhang, X. Zhao, C. Yuan, and F. Ye, “The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma,” Nutrition and Cancer, vol. 63, no. 3, pp. 466–475, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Shankar, S. Ganapathy, and R. K. Srivastava, “Green tea polyphenols: biology and therapeutic implications in cancer,” Frontiers in Bioscience, vol. 12, no. 13, pp. 4881–4899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Khan and H. Mukhtar, “Multitargeted therapy of cancer by green tea polyphenols,” Cancer Letters, vol. 269, no. 2, pp. 269–280, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Luo, G. O. Rankin, N. Juliano, B.-H. Jiang, and Y. C. Chen, “Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFκB-cMyc-p21 pathway,” Food Chemistry, vol. 130, no. 2, pp. 321–328, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Bulzomi, P. Galluzzo, A. Bolli, S. Leone, F. Acconcia, and M. Marino, “The pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals,” Journal of Cellular Physiology, vol. 227, no. 5, pp. 1891–1898, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. D. Lambert, J. Hong, G.-Y. Yang, J. Liao, and C. S. Yang, “Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations,” The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 284S–291S, 2005. View at Google Scholar · View at Scopus
  25. F. Afaq, V. M. Adhami, N. Ahmad, and H. Mukhtar, “Inhibition of ultraviolet B-mediated activation of nuclear factor κB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate,” Oncogene, vol. 22, no. 7, pp. 1035–1044, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Dong, W. Y. Ma, C. Huang, and C. S. Yang, “Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins,” Cancer Research, vol. 57, no. 19, pp. 4414–4419, 1997. View at Google Scholar · View at Scopus
  27. M. Shimizu, A. Deguchi, J. T. E. Lim, H. Moriwaki, L. Kopelovich, and I. B. Weinstein, “(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells,” Clinical Cancer Research, vol. 11, no. 7, pp. 2735–2746, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. V. M. Adhami, I. A. Siddiqui, N. Ahmad, S. Gupta, and H. Mukhtar, “Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer,” Cancer Research, vol. 64, no. 23, pp. 8715–8722, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. D. S. Wheeler, J. D. Catravas, K. Odoms, A. Denenberg, V. Malhotra, and H. R. Wong, “Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1β-dependent proinflammatory signal transduction in cultured respiratory epithelial cells,” Journal of Nutrition, vol. 134, no. 5, pp. 1039–1044, 2004. View at Google Scholar · View at Scopus
  30. H. M. Kim and J. Kim, “The effects of green tea on obesity and type 2 diabetes,” Diabetes and Metabolism Journal, vol. 37, no. 3, pp. 173–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Iso, C. Date, K. Wakai et al., “The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults,” Annals of Internal Medicine, vol. 144, no. 8, pp. 554–562, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C.-H. Wu, F.-H. Lu, C.-S. Chang, T.-C. Chang, R.-H. Wang, and C.-J. Chang, “Relationship among habitual tea consumption, percent body fat, and body fat distribution,” Obesity Research, vol. 11, no. 9, pp. 1088–1095, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. O. H. Ryu, J. Lee, K. W. Lee et al., “Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients,” Diabetes Research and Clinical Practice, vol. 71, no. 3, pp. 356–358, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Fiordaliso, A. Leri, D. Cesselli et al., “Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death,” Diabetes, vol. 50, no. 10, pp. 2363–2375, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. M. V. Blagosklonny, “TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists,” Cell Death and Disease, vol. 4, no. 12, article e964, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Mandel, T. Amit, L. Reznichenko, O. Weinreb, and M. B. H. Youdim, “Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders,” Molecular Nutrition and Food Research, vol. 50, no. 2, pp. 229–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Mandel, G. Maor, and M. B. Youdim, “Iron and α-synuclein in the substantia nigra of MPTP-treated mice: effect of neuroprotective drugs R-apomorphine and green tea polyphenol (-)-epigallocatechin-3-gallate,” Journal of Molecular Neuroscience, vol. 24, no. 3, pp. 401–416, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Rezai-Zadeh, D. Shytle, N. Sun et al., “Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice,” Journal of Neuroscience, vol. 25, no. 38, pp. 8807–8814, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. C.-X. Gong, T. Lidsky, J. Wegiel, L. Zuck, I. Grundke-Iqbal, and K. Iqbal, “Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease,” The Journal of Biological Chemistry, vol. 275, no. 8, pp. 5535–5544, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. A. D. C. Alonso, T. Zaidi, I. Grundke-Iqbal, and K. Iqbal, “Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 12, pp. 5562–5566, 1994. View at Publisher · View at Google Scholar · View at Scopus
  41. P. V. A. Babu and D. Liu, “Green tea catechins and cardiovascular health: an update,” Current Medicinal Chemistry, vol. 15, no. 18, pp. 1840–1850, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. T. M. Buetler, M. Renard, E. A. Offord, H. Schneider, and U. T. Ruegg, “Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species,” The American Journal of Clinical Nutrition, vol. 75, no. 4, pp. 749–753, 2002. View at Google Scholar · View at Scopus
  43. B. J. Petrof, J. B. Shrager, H. H. Stedman, A. M. Kelly, and H. L. Sweeney, “Dystrophin protects the sarcolemma from stresses developed during muscle contraction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 8, pp. 3710–3714, 1993. View at Publisher · View at Google Scholar · View at Scopus
  44. P. E. M. Smith, P. M. A. Calverley, R. H. T. Edwards, G. A. Evans, and E. J. Campbell, “Practical problems in the respiratory care of patients with muscular dystrophy,” The New England Journal of Medicine, vol. 316, no. 19, pp. 1197–1205, 1987. View at Publisher · View at Google Scholar · View at Scopus
  45. M.-H. Disatnik, J. Dhawan, Y. Yu et al., “Evidence of oxidative stress in mdx mouse muscle: studies of the pre- necrotic state,” Journal of the Neurological Sciences, vol. 161, no. 1, pp. 77–84, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Singh, N. Akhtar, and T. M. Haqqi, “Green tea polyphenol epigallocatechi3-gallate: Inflammation and arthritis,” Life Sciences, vol. 86, no. 25-26, pp. 907–918, 2010. View at Publisher · View at Google Scholar · View at Scopus